|
Name of the Intermediate |
CAS |
Application /API Name |
Production status |
|
3,4-Dihydroxybenzaldehyde |
139-85-5 |
Roflumilast/ Fine chemical |
Commercial |
|
2,4-dimethyl-benzenethiol |
13616-82-5 |
Vortioxetine |
Commercial |
|
(2,4-dimethylphenyl)(2-nitrophenyl)sulfane |
1610527-49-5 |
Vortioxetine |
Commercial |
|
Moc-L-Valine. |
74761-42-5 |
Fine chemical |
Commercial |
|
L-Valine methyl ester hydrochloride |
6306-52-1 |
Fine chemical |
Commercial |
|
5,6-Dimethoxy -1-indanone |
2107-69-9 |
Donepezil |
Commercial |
|
5-Bromo-6-methoxy-1-indanone |
187872-11-3 |
Advanced intermediate |
Pilot Scale |
|
1-phenyl-1,2,3,4-tetrahydroisoquinoline |
22990-19-8 |
Solifenacin succinate |
Commercial |
|
N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amino]carbonyl-L-valine Methyl Ester |
154248-99-4 |
Ritonavir |
Commercial |
|
N-Carbobenzyloxy-L-valine |
1149-26-4 |
Valaciclovir |
Commercial |
|
4-Amino -2- chloro-6,7- di methoxy quinazoline |
23680-84-4 |
Alfuzosin/Terazosin/Prazosin/Bunazosin/Doxazosin |
Commercial |
|
2-Chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) |
3140-73-6 |
Pemetrexed, peptide coupling agent |
Commercial |
|
5-Bromo-2-chlorobenzoic acid |
21739-92-4 |
Dapagliflozin ,Empagliflozin,Bexagliflozin |
Commercial |
|
2-Chloro-5-iodobenzoic Acid |
19094-56-5 |
Dapagliflozin ,Empagliflozin,Bexagliflozin |
Pilot scale |
|
2-Bromo-5-hydroxybenzaldehyde |
2973-80-0 |
Crisaborole |
Pilot scale |
|
Methyl carbazate, |
6294-89-9 |
Aprepitant |
Commercial |
|
Isobutyramide |
563-83-7 |
Fine chemical/ |
Commercial |
|
5-amino-2-chloro-4-fluorophenol |
84478-72-8 |
Advanced intermediate |
Pilot Scale |
|
3-amino-4-fluorophenol |
62257-16-3 |
Advanced intermediate |
Pilot Scale |
|
2-Chloro-4-fluorophenol |
1996-41-4 |
Advanced intermediate |
Pilot Scale |
Note : All Transactions are carried out in conformity with the patent laws applicable in the user country. Responsibility with respect to third party’s patent rights in a specific country lies exclusively with the buyer.